Neurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide

Brain Research

Volumn 762, Issue 1-2, 1997, Pages 79-88

  Barth, Alain ^a   Newell, David W ^a   Nguyen, Loan B ^a   Winn, H Richard ^a   Wender, Regina ^a   Meno, Joseph R ^a   Janigro, Damir ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adenosine deaminase; Excitotoxicity; Ischemia; Neuron glia interaction; Neuroprotection; NOS inhibitor; Organotypic hippocampal culture

Indexed keywords

9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE DERIVATIVE; LINSIDOMINE; N(G) NITROARGININE; NITRIC OXIDE; THEOPHYLLINE;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; HIPPOCAMPUS; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

2-CHLOROADENOSINE; ADENINE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; ANIMALS, NEWBORN; BRAIN ISCHEMIA; CELL SURVIVAL; ENZYME INHIBITORS; HIPPOCAMPUS; NEURONS; NEUROTOXINS; NITRIC OXIDE; ORGAN CULTURE TECHNIQUES; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; THEOBROMINE; THEOPHYLLINE; XANTHINES;

EID: 0030742435     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00348-X     Document Type: Article

References (45)

1. Bhardwaj A., Northington F.J., Koehler R.C., Stiefel T., Hanley D.F., Traystman R.J. Adenosine modulates N-methyl-D-aspartate-stimulated hippocampal nitric oxide production in vivo. Stroke. 26:1995;1627-1633.
2. 2-stimulated swelling and Cl in brain slices. Brain Res. 154:1978;195-202.
3. Carrera C.J., Terai C., Lotz M., Curd J.G., Piro L.D., Beutler E., Carson D.A. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. J. Clin. Invest. 86:1990;1480-1488.
4. 3H]acetylcholine release from different areas of the rat hippocampus. J. Neurochem. 63:1994;207-214.
5. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
6. Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16:1996;2479-2487.
7. de Mendonca A., Ribeiro J.A. 2-Chloroadenosine decreases long-term potentiation in the hippocampal CA1 area of the rat. Neurosci. Lett. 118:1990;107-111.
8. de Mendonca A., Ribeiro J.A. Adenosine inhibits the NMDA receptor-mediated excitatory postsynaptic potential in the hippocampus. Brain Res. 606:1993;351-356.
9. de Mendonca A., Ribeiro J.A. Endogenous adenosine modulates long-term potentiation in the hippocampus. Neuroscience. 62:1994;385-390.
10. de Mendonca A., Sebastiao A.M., Ribeiro J.A. Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation. NeuroReport. 6:1995;1097-1100.
11. Dunwiddie T.V., Diao L. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther. 268:1994;537-545.
12. Dunwiddie T.V., Fredholm B.B. Adenosine A1 receptors inhibit adenylate cyclase activity and transmitter release and hyperpolarize pyramidal neurons in the rat hippocampus. J. Pharmacol. Exp. Ther. 249:1989;31-37.
13. el Etr M., Marin P., Tence M., Delumeau J.C., Cordier J., Glowinski J., Premont J. 2-Chloroadenosine potentiates the α1-adrenergic activation of phospholipase C through a mechanism involving arachidonic acid and glutamate in striatal astrocytes. J. Neurosci. 12:1992;1363-1369.
14. Faraci F.M., Brian J.E.J. Nitric oxide and the cerebral circulation. Stroke. 25:1994;692-703.
15. M.D. Ginsberg, R. Busto, M.Y. Globus, Measurement of glutamate and other neurotransmitters in ischemic brain by microdialysis: Effects of hyperthermia and hypothermia, in: S.T. Ohnishi and T. Ohnishi (Eds.), Central Nervous System Trauma: Research Techniques, CRC, Boca Raton, FL, 1995, pp. 395-403.
16. Hsu S.S., Meno J.R., Zhou J.G., Gordon E.L., Winn H.R. Influence of hyperglycemia on cerebral adenosine production during ischemia and reperfusion. Am. J. Physiol. 261:1991;H398-403.
17. Hsu S.S., Newell D.W., Tucker A., Malouf A.T., Winn H.R. Adenosinergic modulation of CA1 neuronal tolerance to glucose deprivation in organotypic hippocampal cultures. Neurosci. Lett. 178:1994;189-192.
18. Janigro D., Nguyen T., Gordon E.L., Winn H.R. Physiological properties of ATP-activated cation channels in rat microvascular endothelial cells. Am. J. Physiol. 270:1996;H1423-H1434.
19. Janigro D., Wender R., Ransom G., Tinklepaugh D.L., Winn H.R. Adenosine-induced release of nitric oxide from cortical astrocytes. Neuroreport. 7:1996;1640-1644.
20. Ko K.R., Ngai A.C., Winn H.R. Role of adenosine in regulation of regional cerebral blood flow in sensory cortex. Am. J. Physiol. 259:1990;H1703-8.
21. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
22. Lupica C.R., Proctor W.R., Dunwiddie T.V. Presynaptic inhibition of excitatory synaptic transmission by adenosine in the rat hippocampus: Analysis of unitary EPSP variance measured by whole cell recording. J. Neurosci. 12:1992;3753-3764.
23. Bartrup J.T., Stone T.W. Activation of NMDA receptor-coupled channels suppresses the inhibitory action of adenosine on hippocampal slices. Brain Res. 530:1990;330-334.
24. Maclis J.D., Madison R.D. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiologic status: A fluorescence scale of membrane integrity. J. Neurosci. Methods. 31:1990;43-46.
25. Mitchell J.B., Lupica C.R., Dunwiddie T.V. Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci. 13:1993;3439-3447.
26. Miyazaki S., Katayama Y., Furuichi M., Kano T., Yoshino A., Tsubokawa T. N-Methyl-D-aspartate receptor-mediated, prolonged afterdischarges of CA1 pyramidal cells following transient cerebral ischemia in the rat hippocampus in vivo. Brain Res. 657:1994;325-329.
27. Moncada S.E., Palmer R.M., Higgs A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-141.
28. Newell D.W., Barth A., Malouf A.T. Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures. Brain Res. 675:1995;38-44.
29. Newell D.W., Barth A., Papermaster V., Malouf A.T. Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J. Neurosci. 15:1995;7702-7711.
30. Ngai A.C., Meno J.R., Winn H.R. L-NNA suppresses cerebrovascular response and evoked potentials during sensorymotor stimulation in the rat. Am. J. Physiol. 269:1995;H1803-H1810.
31. O'Reagan M.H., Simpson R.E., Perkins L.M., Phillis J.W. The selective A2 adenosine agonist CGS 21680 enhances excitatory aminoacid release from the ischemic rat cerebral cortex. Neurosci. Lett. 138:1992;169-172.
32. Poli A., Lucchi R., Vibio M., Barnabei O. Adenosine and glutamate modulate each other's release from rat hippocampal synaptosomes. J. Neurochem. 57:1991;298-306.
33. i in hippocampal astrocytes in situ. J. Neurochem. 65:1995;1515-1523.
34. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Adenosine and brain ischemia. Cerebrovasc. Brain Metabol. Rev. 4:1992;346-369.
35. Schubert P., Ferroni S., Mager R. Pharmacological blockade of Cl pumps or Cl channels reduces the adenosine-mediated depression of stimulus train-evoked Ca fluxes in rat hippocampal slices. Neurosci. Lett. 124:1991;174-177.
36. Schubert P., Kreutzberg G.W. Cerebral protection by adenosine. Acta Neurochirurg. 57:1993;80-88.
37. Schwabe U., Lorenzen A., Grun S. Adenosine receptors in the central nervous system. J. Neural Transm. Suppl. 34:1991;149-155.
38. Sebastiao A.M., Ribeiro J.A. Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus. Neurosci. Lett. 138:1992;41-44.
39. Sekino Y., Ito K., Miyakawa H., Kato H., Kuroda Y. Adenosine (A2) antagonist inhibits induction of long-term potentiation of evoked synaptic potentials but not of the population spike in hippocampal CA1 neurons. Biochem. Biophys. Res. Commun. 181:1991;1010-1014.
40. Stevens C.F., Wang Y. Reversal of long-term potentiation by inhibitors of haem oxygenase. Nature. 364:1993;147-149.
41. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:1991;173-182.
42. Weisskopf M.G., Castillo P.E., Zalutsky R.A., Nicoll R.A. Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science. 265:1994;1878-1882.
43. Winn H.R., Rubio R., Berne R.M. The role of adenosine in the regulation of cerebral blood flow. J. Cerebr. Blood Flow Metab. 1:1981;239-244.
44. Winn H.R., Rubio R., Berne R.M. Brain adenosine production in the rat during 60 seconds of ischemia. Circ. Res. 45(4):1979;486-492.
45. Zhou J.G., Meno J.R., Hsu S.S., Winn H.R. Effects of theophylline and cyclohexyladenosine on brain injury following normo- and hyperglycemic ischemia: A histopathologic study in the rat. J. Cerebr. Blood Flow Metab. 14:1994;166-173.